User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 14 results.
    • Journal article
    Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.
    Wulf, Gerald G Altmann, Bettina Ziepert, Marita D'Amore, Francesco Held, Gerhard Greil, Richard Tournilhac, Olivier Relander, Thomas Viardot, Andreas Wilhelm, Martin Wilhelm, Christian Pezzutto, Antonio Zijlstra, Josee M Van Den Neste, Eric[UCL] Lugtenburg, Pieternella J Doorduijn, Jeanette K Gelder, Michel van van Imhoff, Gustaaf W Zettl, Florian Braulke, Friederike Nickelsen, Maike Glass, Bertram Rosenwald, Andreas Gaulard, Philippe Loeffler, Markus Pfreundschuh, Michael Schmitz, Norbert Trümper, Lorenz ACT-2 study investigators (2021) Leukemia — Vol. 35, no.1, p. 143-155 (2021)
    • Journal article
    Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study.
    Dartigeas, Caroline Van Den Neste, Eric[UCL] Léger, Julie Maisonneuve, Hervé Berthou, Christian Dilhuydy, Marie-Sarah De Guibert, Sophie Leprêtre, Stéphane Béné, Marie C Nguyen-Khac, Florence Letestu, Rémi Cymbalista, Florence Rodon, Philippe Aurran-Schleinitz, Thérèse Vilque, Jean-Pierre Tournilhac, Olivier Mahé, Béatrice Laribi, Kamel Michallet, Anne-Sophie Delmer, Alain Feugier, Pierre Lévy, Vincent Delépine, Roselyne Colombat, Philippe Leblond, Véronique CLL 2007 SA investigators French Innovative Leukemia Organization (FILO) (2018) The Lancet. Haematology — Vol. 5, no.2, p. e82-e94 (2018)
    • Journal article
    Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma.
    Duell, Johannes Maddocks, Kami J González-Barca, Eva Jurczak, Wojciech Liberati, Anna Marina De Vos, Sven Nagy, Zsolt Obr, Aleš Gaidano, Gianluca Abrisqueta, Pau Kalakonda, Nagesh André, Marc[UCL] Dreyling, Martin Menne, Tobias Tournilhac, Olivier Augustin, Marinela Rosenwald, Andreas Dirnberger-Hertweck, Maren Weirather, Johannes Ambarkhane, Sumeet Salles, Gilles (2021) Haematologica — Vol. 106, no. 9, p. 2417-2426 (2021)
    • Journal article
    Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience
    Adès, Lionel Ferrant, Augustin[UCL] Guerci, Agnes Raffoux, Emmanuel Sanz, Miguel Chevallier, Patrice Lapusan, Simona Recher, Christian Thomas, Xavier Rayon, Consuelo Castaigne, Sylvie Tournilhac, Olivier de Botton, Stephane Ifrah, Norbert Cahn, Jean-Yves Solary, Eric Gardin, Claude Fegeux, Nathalie Bordessoule, Dominique Meyer-Monard, Sandrine Vey, Norbert Dombret, Herve Degos, Laurent Chevret, Sylvie Fenaux, Pierre (2010) Blood — Vol. 115, no. 9, p. 1690-1696 (2010)
    • Journal article
    Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study.
    Salles, Gilles Duell, Johannes González Barca, Eva Tournilhac, Olivier Jurczak, Wojciech Liberati, Anna Marina Nagy, Zsolt Obr, Aleš Gaidano, Gianluca André, Marc[UCL] Kalakonda, Nagesh Dreyling, Martin Weirather, Johannes Dirnberger-Hertweck, Maren Ambarkhane, Sumeet Fingerle-Rowson, Günter Maddocks, Kami (2020) The Lancet. Oncology — Vol. 21, no. 7, p. 978-988 (2020)
    • Journal article
    Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
    Le Gouill, Steven Thieblemont, Catherine Oberic, Lucie Moreau, Anne Bouabdallah, Krimo Dartigeas, Caroline Damaj, Gandhi Gastinne, Thomas Ribrag, Vincent Feugier, Pierre Casasnovas, Olivier Zerazhi, Hacène Haioun, Corinne Maisonneuve, Hervé Houot, Roch Jardin, Fabrice Van Den Neste, Eric[UCL] Tournilhac, Olivier Le Dû, Katell Morschhauser, Franck Cartron, Guillaume Fornecker, Luc-Matthieu Canioni, Danielle Callanan, Mary Béné, Marie C Salles, Gilles Tilly, Hervé Lamy, Thierry Gressin, Remy Hermine, Olivier LYSA Group Bosly, André[UCL] (2017) New England Journal of Medicine — Vol. 377, no.13, p. 1250-1260 (2017)
    • Journal article
    BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
    Herbaux, Charles Kornauth, Christoph Poulain, Stéphanie Chong, Stephen J F Collins, Mary C Valentin, Rebecca Hackett, Liam Tournilhac, Olivier Lemonnier, François Dupuis, Jehan Daniel, Adrien Tomowiak, Cecile Laribi, Kamel Renaud, Loïc Roos-Weil, Damien Rossi, Cedric Van Den Neste, Eric[UCL] Leyronnas, Cecile Merabet, Fatiha Malfuson, Jean Valère Tiab, Mourad Ysebaert, Loïc Ng, Samuel Morschhauser, Franck Staber, Philipp B Davids, Matthew S (2021) Blood — Vol. 137, no.25, p. 3495-3506 (2021)
    • Journal article
    Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.
    Lepretre, Stephane Aurran, Therese Mahé, Beatrice Cazin, Bruno Tournilhac, Olivier Maisonneuve, Herve Casasnovas, Olivier Delmer, Alain Leblond, Veronique Royer, Bruno Corront, Bernadette Chevret, Sylvie Delépine, Roselyne Vaudaux, Sandrine Van Den Neste, Eric Béné, Marie Christine Letestu, Remi Cymbalista, Florence Feugier, Pierre (2012) Blood — Vol. 119, no.22, p. 5104-5110 (2012)
    • Journal article
    Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia.
    Feugier, Pierre Aurran, Thérèse Mahé, Béatrice Letestu, Remi Nguyen-Khac, Florence Cazin, Bruno Tournilhac, Olivier Maisonneuve, Hervé Casasnovas, Olivier Delmer, Alain Leblond, Véronique Royer, Bruno Corront, Bernadette Chevret, Sylvie Delépine, Roselyne Vaudaux, Sandrine Van Den Neste, Eric[UCL] Béné, Marie-Christine Cymbalista, Florence Ross-Weil, Damien Leprêtre, Stéphane (2018) Haematologica — Vol. 103, no.7, p. e304-e306 (2018)
    • Journal article
    Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study.
    Morel, Alexandre Brière, Josette Lamant, Laurence Loschi, Michaël Haioun, Corinne Delarue, Richard Tournilhac, Olivier Bachy, Emmanuel Sonet, Anne[UCL] Amorim, Sandy Laurent, Camille Gaulard, Philippe Tilly, Hervé Sibon, David (2017) European Journal of Cancer — Vol. 83, p. 146-153 (2017)
    • Journal article
    Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia
    Dartigeas, Caroline Van Den Neste, Eric[UCL] Berthou, Christian Maisonneuve, Hervé Leprêtre, Stéphane Dilhuydy, Marie-Sarah Béné, Marie-Christine Nguyen-Khac, Florence Letestu, Rémi Cymbalista, Florence De Guibert, Sophie Aurran, Thérèse Laribi, Kamel Vilque, Jean-Pierre Tournilhac, Olivier Delmer, Alain Feugier, Pierre Cazin, Bruno Michallet, Anne-Sophie Lévy, Vincent Troussard, Xavier Delepine, Roselyne Tavernier, Elsa Colombat, Philippe Leblond, Véronique (2016) Leukemia and Lymphoma — Vol. 57, no. 2, p. 328-334 (2016)
    • Journal article
    Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety in the phase II L-MIND study.
    Duell, Johannes Abrisqueta, Pau André, Marc[UCL] Gaidano, Gianluca Gonzales-Barca, Eva Jurczak, Wojciech Kalakonda, Nagesh Liberati, Anna Marina Maddocks, Kami J Menne, Tobias Nagy, Zsolt Tournilhac, Olivier Kuffer, Christian Bakuli, Abhishek Amin, Aasim Gurbanov, Konstantin Salles, Gilles (2024) Haematologica — Vol. 109, no. 2, p. 553-566 (2024)
    • Journal article
    Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.
    Dupuis, Jehan Bachy, Emmanuel Morschhauser, Franck Cartron, Guillaume Fukuhara, Noriko Daguindau, Nicolas Casasnovas, René-Olivier Snauwaert, Sylvia Gressin, Remy Fox, Christopher P d'Amore, Francesco Annibale Staber, Philipp B Tournilhac, Olivier Bouabdallah, Krimo Thieblemont, Catherine André, Marc[UCL] Rai, Shinya Ennishi, Daisuke Gkasiamis, Argyrios Nishio, Mitsufumi Fornecker, Luc-Matthieu Delfau-Larue, Marie-Helene Sako, Nouhoum Mule, Sebastien de Leval, Laurence Gaulard, Philippe Tsukasaki, Kunihiro Lemonnier, François (2024) The Lancet. Haematology — Vol. 11, no.6, p. e406-e414 (2024)
    • Journal article
    Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC.
    Sutton, Laurent Chevret, Sylvie Tournilhac, Olivier Diviné, Marine Leblond, Véronique Corront, Bernadette Leprêtre, Stéphane Eghbali, Houchingue Van Den Neste, Eric Michallet, Mauricette Maloisel, Frédéric Bouabdallah, Krimo Decaudin, Didier Berthou, Christian Brice, Pauline Gonzalez, Hugo Chapiro, Elise Radford-Weiss, Isabelle Leporrier, Nathalie Maloum, Karim Nguyen-Khac, Florence Davi, Frédéric Lejeune, Julie Merle-Béral, Hélène Leporrier, Michel (2011) Blood — Vol. 117, no.23, p. 6109-6119 (2011)